In a letter to Purdue Pharma, Elijah Cummings, D-Md., the committee’s chairman, and Mark DeSaulnier, D-Calif., asked the company to provide a list of Sackler family members who have served on the board or worked as officers.
Lawmakers also requested documents prepared for the Sackler family about the marketing strategies for OxyContin and communications between company employees and family members.
While Purdue Pharma is facing hundreds of lawsuits for its alleged role in fueling the nationwide opioid crisis by misleading providers and patients about the safety of OxyContin, attention is shifting to the Sackler family as well.
A lawsuit filed in Massachusetts named the Sackler family as defendants. The lawsuit claims that family members were involved in the company’s sales tactics and knew about the risks of its opioids.
Purdue Pharma denies the allegations.
Read the full report here.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.